Phibro Animal Health Corp
PAHC32.200USD
-0.440-1.35%
收盤 08/27, 16:00（美東）報價延遲15分鐘
1.31B總市值
41.05本益比TTM
關於 Phibro Animal Health Corp 公司
Phibro Animal Health Corporation 是一家全球多元化動物保健和礦物質營養公司。該公司開發、生產和銷售一系列食品和伴侶動物產品，包括家禽、豬、肉牛和奶牛、水產養殖和狗。該公司向 80 多個國家的大約 4,200 名客戶銷售約 750 條產品線。該公司有三個部門：動物保健、礦物質營養和性能產品。其動物保健部門開發、生產和銷售約 280 條產品線，包括抗菌藥、抗球蟲藥和相關產品；營養特種產品；和疫苗。礦物質營養部門包括鋅、錳、銅、鐵和其他化合物等微量礦物質的配方和濃度，重點關注北美客戶。性能產品部門生產和銷售用於個人護理、工業化學品和化學催化劑行業的特種成分。
公司簡介
公司代碼PAHC
公司名稱Phibro Animal Health Corp
上市日期Apr 11, 2014
CEOMr. Jack C. Bendheim
員工數量1940
證券類型Ordinary Share
年結日Apr 11
公司地址Glenpointe Centre East, 3Rd Floor
城市TEANECK
上市交易所NASDAQ Global Market Consolidated
國家United States of America
郵編07666
電話12013297300
網址https://www.pahc.com/
公司代碼PAHC
上市日期Apr 11, 2014
CEOMr. Jack C. Bendheim
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
35.18K
+17.28%
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
34.84K
+16.15%
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
30.00K
+20.00%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
--
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
--
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
--
Ms. Carol A. Wrenn
Ms. Carol A. Wrenn
Independent Director
Independent Director
1.00K
--
Mr. Sam Gejdenson
Mr. Sam Gejdenson
Independent Director
Independent Director
--
--
Ms. Judith A. Weinstein
Ms. Judith A. Weinstein
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
--
--
Ms. Joyce J. Lee
Ms. Joyce J. Lee
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Larry Lee Miller
Mr. Larry Lee Miller
Chief Operating Officer
Chief Operating Officer
35.18K
+17.28%
Mr. Glenn C. David
Mr. Glenn C. David
Chief Financial Officer
Chief Financial Officer
34.84K
+16.15%
Mr. E. Thomas (Tom) Corcoran
Mr. E. Thomas (Tom) Corcoran
Independent Director
Independent Director
30.00K
+20.00%
Mr. Daniel M. Bendheim
Mr. Daniel M. Bendheim
Executive Vice President - Corporate Strategy, Director
Executive Vice President - Corporate Strategy, Director
3.96K
--
Mr. Jonathan Bendheim
Mr. Jonathan Bendheim
Senior Vice President - Global Technology and Talent, Director
Senior Vice President - Global Technology and Talent, Director
3.27K
--
Mr. Anthony Andolino
Mr. Anthony Andolino
Vice President - Finance, Treasurer
Vice President - Finance, Treasurer
1.79K
--
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
MFAs and Other
181.65M
52.22%
Nutritional specialties
43.35M
12.46%
Vaccines
33.38M
9.60%
地區USD
名稱
營收
佔比
United States
209.94M
60.36%
Latin America and Canada
70.75M
20.34%
Europe & Middle East & Africa
38.91M
11.19%
Asia Pacific
28.22M
8.11%
業務
地區
業務USD
名稱
營收
佔比
MFAs and Other
181.65M
52.22%
Nutritional specialties
43.35M
12.46%
Vaccines
33.38M
9.60%
股東統計
更新時間: 8月23日 週六
更新時間: 8月23日 週六
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
14.45%
The Vanguard Group, Inc.
7.58%
State Street Global Advisors (US)
4.46%
Acadian Asset Management LLC
3.56%
ExodusPoint Capital Management, LP
3.34%
其他
66.61%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
14.45%
The Vanguard Group, Inc.
7.58%
State Street Global Advisors (US)
4.46%
Acadian Asset Management LLC
3.56%
ExodusPoint Capital Management, LP
3.34%
其他
66.61%
股東類型
持股股東
佔比
Investment Advisor
56.03%
Investment Advisor/Hedge Fund
28.92%
Hedge Fund
15.11%
Research Firm
2.79%
Pension Fund
1.76%
Individual Investor
0.65%
Bank and Trust
0.39%
Corporation
0.29%
Sovereign Wealth Fund
0.05%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
377
20.85M
102.34%
-3.11M
2025Q1
383
21.67M
106.42%
-2.98M
2024Q4
360
21.95M
107.94%
-1.91M
2024Q3
348
21.46M
105.50%
-2.61M
2024Q2
357
21.32M
104.83%
-3.05M
2024Q1
350
21.49M
105.66%
-2.40M
2023Q4
349
21.13M
103.91%
-1.66M
2023Q3
339
20.38M
100.19%
-2.22M
2023Q2
341
20.61M
101.32%
-2.12M
2023Q1
350
20.77M
102.13%
-2.00M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
3.10M
15.24%
-58.95K
-1.86%
Mar 31, 2025
The Vanguard Group, Inc.
1.52M
7.45%
+6.78K
+0.45%
Mar 31, 2025
State Street Global Advisors (US)
920.19K
4.52%
-26.64K
-2.81%
Mar 31, 2025
Acadian Asset Management LLC
782.94K
3.84%
+4.14K
+0.53%
Mar 31, 2025
Renaissance Technologies LLC
705.30K
3.46%
+147.50K
+26.44%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
643.91K
3.16%
-73.20K
-10.21%
Mar 31, 2025
Geode Capital Management, L.L.C.
547.09K
2.69%
+31.11K
+6.03%
Mar 31, 2025
Castleknight Management LP
417.75K
2.05%
+28.31K
+7.27%
Mar 31, 2025
Nuveen LLC
481.80K
2.37%
-105.20K
-17.92%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月6日 週三
更新時間: 8月6日 週三
機構名稱
佔比
Brandes US Small-Mid Cap Value ETF
1.22%
SPDR S&P Pharmaceuticals ETF
0.86%
Lattice Hartford Multifactor Small Cap ETF
0.71%
Invesco S&P SmallCap 600 Pure Growth ETF
0.7%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
0.53%
Invesco NASDAQ Future Gen 200 ETF
0.47%
Invesco S&P SmallCap Health Care ETF
0.36%
Royce Quant Small-Cap Quality Value ETF
0.28%
Zacks Small/Mid Cap ETF
0.27%
Harbor Human Capital Factor US Small Cap ETF
0.21%
查看更多
Brandes US Small-Mid Cap Value ETF
佔比1.22%
SPDR S&P Pharmaceuticals ETF
佔比0.86%
Lattice Hartford Multifactor Small Cap ETF
佔比0.71%
Invesco S&P SmallCap 600 Pure Growth ETF
佔比0.7%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
佔比0.53%
Invesco NASDAQ Future Gen 200 ETF
佔比0.47%
Invesco S&P SmallCap Health Care ETF
佔比0.36%
Royce Quant Small-Cap Quality Value ETF
佔比0.28%
Zacks Small/Mid Cap ETF
佔比0.27%
Harbor Human Capital Factor US Small Cap ETF
佔比0.21%
分紅派息
近5年累計派現
97.17M
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
Feb 04, 2025
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 26, 2025 going ex on Mar 05, 2025
Mar 05, 2025
Mar 26, 2025
Mar 05, 2025
Nov 05, 2024
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 18, 2024 going ex on Nov 27, 2024
Nov 27, 2024
Dec 18, 2024
Nov 27, 2024
Jul 30, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 25, 2024 going ex on Sep 04, 2024
Sep 04, 2024
Sep 25, 2024
Sep 04, 2024
May 07, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 26, 2024 going ex on Jun 05, 2024
Jun 05, 2024
Jun 26, 2024
Jun 05, 2024
Feb 06, 2024
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 27, 2024 going ex on Mar 05, 2024
Mar 06, 2024
Mar 27, 2024
Mar 05, 2024
Nov 06, 2023
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 20, 2023 going ex on Nov 28, 2023
Nov 29, 2023
Dec 20, 2023
Nov 28, 2023
Jul 25, 2023
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Sep 27, 2023 going ex on Sep 05, 2023
Sep 06, 2023
Sep 27, 2023
Sep 05, 2023
May 01, 2023
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Jun 28, 2023 going ex on Jun 06, 2023
Jun 07, 2023
Jun 28, 2023
Jun 06, 2023
Feb 06, 2023
PAHC.NB Interim Cash Dividend of gross USD 0.12 paid on Mar 22, 2023 going ex on Feb 28, 2023
Mar 01, 2023
Mar 22, 2023
Feb 28, 2023
Nov 07, 2022
PAHC.NB Final Cash Dividend of gross USD 0.12 paid on Dec 21, 2022 going ex on Nov 29, 2022
Nov 30, 2022
Dec 21, 2022
Nov 29, 2022
查看更多
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
